BofA raised the firm’s price target on Allstate (ALL) to $285 from $263 and keeps a Buy rating on the shares. Following a meeting with management, the firm says its positive view remains unchanged and it continues to believe that underwriting margins will continue to expand. The price of Allstate shares trade at a discount to fair, intrinsic value, argues the analyst, who remains “comfortably confident” in the firm’s recent prediction that Allstate’s net policycount growth will inflect positive in the first half of 2025.
Discover the Best Stocks and Maximize Your Portfolio:
- See what stocks are receiving strong buy ratings from top-rated analysts.
- Filter, analyze, and streamline your search for investment opportunities with TipRanks’ Stock Screener.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on ALL:
- Trian exits Disney stake, takes new position in Ferguson
- Allstate price target raised to $267 from $231 at Jefferies
- Allstate price target raised to $228, named a ‘Top Pick’ at Morgan Stanley
- Allstate price target raised to $186 from $175 at Wells Fargo
- Allstate Corp Shows Strong Q3 Performance Amid Challenges